Advertisement
Screener

ONYX PHARMACEUTICALS INC Share-based Payment Arrangement, Expense

ONYX PHARMACEUTICALS INC Share-based Payment Arrangement, Expense

ONYX PHARMACEUTICALS INC reported Share-based Payment Arrangement, Expense of $12.70 million for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-09.

Discontinued › Expense Statement › Operating Expenses

us-gaap:AllocatedShareBasedCompensationExpense · last filed 2013-08-09

  • ONYX PHARMACEUTICALS INC share-based payment arrangement, expense for the quarter ending 2013-06-30 was $12.70M, a 16.51% increase year-over-year.
  • ONYX PHARMACEUTICALS INC share-based payment arrangement, expense for the quarter ending 2013-03-31 was $8.80M, a 29.41% increase year-over-year.
  • ONYX PHARMACEUTICALS INC share-based payment arrangement, expense for the quarter ending 2012-12-31 was $8.83M, a 121.20% increase year-over-year.
  • ONYX PHARMACEUTICALS INC share-based payment arrangement, expense for the quarter ending 2012-09-30 was $8.80M, a 1.15% increase year-over-year.
  • ONYX PHARMACEUTICALS INC share-based payment arrangement, expense for fiscal 2012 was $35.33M, a 33.86% increase from fiscal 2011.
  • ONYX PHARMACEUTICALS INC share-based payment arrangement, expense for fiscal 2011 was $26.39M, a 19.32% increase from fiscal 2010.
  • ONYX PHARMACEUTICALS INC share-based payment arrangement, expense for fiscal 2010 was $22.12M, a 4.92% increase from fiscal 2009.
  • ONYX PHARMACEUTICALS INC share-based payment arrangement, expense for fiscal 2009 was $21.08M.
Period endShare-based Payment Arrangement, Expense 3 monthShare-based Payment Arrangement, Expense 6 monthShare-based Payment Arrangement, Expense 9 monthShare-based Payment Arrangement, Expense 12 month
2013-06-30$12.70M
10-Q · filed 2013-08-09
$21.40M
10-Q · filed 2013-08-09
$30.33M
derived: sum of 3 quarters · filed 2013-08-09
$39.13M
derived: sum of 4 quarters · filed 2013-08-09
2013-03-31$8.80M
10-Q · filed 2013-05-08
$17.63M
derived: sum of 2 quarters · filed 2013-05-08
$26.43M
derived: sum of 3 quarters · filed 2013-05-08
$37.33M
derived: sum of 4 quarters · filed 2013-08-09
2012-12-31$8.83M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28
$17.63M
derived: sum of 2 quarters · filed 2013-02-28
$28.53M
derived: sum of 3 quarters · filed 2013-08-09
$35.33M
10-K · filed 2013-02-28
2012-09-30$8.80M
10-Q · filed 2012-11-02
$19.70M
derived: sum of 2 quarters · filed 2013-08-09
$26.50M
10-Q · filed 2012-11-02
$30.49M
derived: sum of 4 quarters · filed 2013-08-09
2012-06-30$10.90M
10-Q · filed 2013-08-09
$17.70M
10-Q · filed 2013-08-09
$21.69M
derived: sum of 3 quarters · filed 2013-08-09
$30.39M
derived: sum of 4 quarters · filed 2013-08-09
2012-03-31$6.80M
10-Q · filed 2013-05-08
$10.79M
derived: sum of 2 quarters · filed 2013-05-08
$19.49M
derived: sum of 3 quarters · filed 2013-05-08
$27.89M
derived: sum of 4 quarters · filed 2013-05-08
2011-12-31$3.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28
$12.69M
derived: sum of 2 quarters · filed 2013-02-28
$21.09M
derived: sum of 3 quarters · filed 2013-02-28
$26.39M
10-K · filed 2013-02-28
2011-09-30$8.70M
10-Q · filed 2012-11-02
$17.10M
derived: sum of 2 quarters · filed 2012-11-02
$22.40M
10-Q · filed 2012-11-02
$28.02M
derived: sum of 4 quarters · filed 2013-02-28
2011-06-30$8.40M
10-Q · filed 2012-08-06
$14.20M
10-Q · filed 2012-08-06
$19.32M
derived: sum of 3 quarters · filed 2013-02-28
$25.22M
derived: sum of 4 quarters · filed 2013-02-28
2011-03-31$5.40M
10-Q · filed 2012-05-04
$10.92M
derived: sum of 2 quarters · filed 2013-02-28
$16.82M
derived: sum of 3 quarters · filed 2013-02-28
$22.62M
derived: sum of 4 quarters · filed 2013-02-28
2010-12-31$5.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28
$11.42M
derived: sum of 2 quarters · filed 2013-02-28
$17.22M
derived: sum of 3 quarters · filed 2013-02-28
$22.12M
10-K · filed 2013-02-28
2010-09-30$5.90M
10-Q · filed 2011-11-03
$11.70M
derived: sum of 2 quarters · filed 2011-11-03
$16.60M
10-Q · filed 2011-11-03
2010-06-30$5.80M
10-Q · filed 2011-08-09
$10.70M
10-Q · filed 2011-08-09
2009-12-31$21.08M
10-K · filed 2012-02-27